Biotech News
Related news
IRIXIRIDEX2026-11-17 21:05 EST
Iridex Reports Third Quarter 2026 Financial Results
IRIXIRIDEX2026-11-03 21:05 EST
Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
MGTXMeiraGTx2026-11-12 13:00 EST
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
ICCMIceCure Medical2026-11-11 13:30 EST
IceCure Medical to Report Third Quarter 2026 Financial and Operating Results on November 18, 2026
XTNTXtant Medical2026-11-10 13:00 EST
Xtant Medical to Announce Third Quarter 2026 Financial Results on November 16, 2026
HYPRHyperfine2026-11-09 21:05 EST
Hyperfine, Inc. Reports Third Quarter 2026 Financial Results
TMCITreace Medical Concepts2026-11-06 12:05 EST
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
CVRXCVRx2026-11-05 21:05 EST
CVRx Reports Third Quarter 2026 Financial and Operating Results
IRTCiRhythm2026-11-05 21:05 EST
iRhythm Holdings Announces Third Quarter 2026 Financial Results
AORTArtivion2026-11-05 21:05 EST
Artivion Reports Third Quarter 2026 Financial Results
IRIDEX
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...
Recent company news
IRIXIRIDEX2026-11-17 21:05 EST
Iridex Reports Third Quarter 2026 Financial Results
IRIXIRIDEX2026-11-03 21:05 EST
Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026
IRIXIRIDEX2026-10-12 11:00 EST
Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
Stock data
- Close
- 0.47 USD
- Market cap
- 20.37M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
